BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 31768781)

  • 1. The D2 and D3 Sublineages of Human Papilloma Virus 16-Positive Cervical Cancer in Guatemala Differ in Integration Rate and Age of Diagnosis.
    Lou H; Boland JF; Torres-Gonzalez E; Albanez A; Zhou W; Steinberg MK; Diaw L; Mitchell J; Roberson D; Cullen M; Garland L; Bass S; Burk RD; Yeager M; Wentzensen N; Schiffman M; Freites EA; Gharzouzi E; Mirabello L; Dean M
    Cancer Res; 2020 Sep; 80(18):3803-3809. PubMed ID: 32631904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of integration patterns of human papilloma virus and single nucleotide polymorphisms on immune- or DNA repair-related genes in cervical cancer patients.
    Joo J; Omae Y; Hitomi Y; Park B; Shin HJ; Yoon KA; Sawai H; Tsuiji M; Hayashi T; Kong SY; Tokunaga K; Kim JY
    Sci Rep; 2019 Sep; 9(1):13132. PubMed ID: 31511581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cis-regulatory effect of HPV integration is constrained by host chromatin architecture in cervical cancers.
    Singh AK; Walavalkar K; Tavernari D; Ciriello G; Notani D; Sabarinathan R
    Mol Oncol; 2024 May; 18(5):1189-1208. PubMed ID: 38013620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ViFi: accurate detection of viral integration and mRNA fusion reveals indiscriminate and unregulated transcription in proximal genomic regions in cervical cancer.
    Nguyen ND; Deshpande V; Luebeck J; Mischel PS; Bafna V
    Nucleic Acids Res; 2018 Apr; 46(7):3309-3325. PubMed ID: 29579309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The analysis of HPV integration sites based on nanopore sequencing and the profiling changes along the course of photodynamic therapy.
    Li X; Wei X; Liu X; Wang N; Xu F; Liu X; Li Y; Zhou Y; Tang H; Bian M; Hou Y; Zhang L; Wang W; Liu Q
    BMC Cancer; 2023 Nov; 23(1):1052. PubMed ID: 37914994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of integration in oncogenic progression of HPV-associated cancers.
    McBride AA; Warburton A
    PLoS Pathog; 2017 Apr; 13(4):e1006211. PubMed ID: 28384274
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating cell-free HPV DNA is a strong marker for disease severity in cervical cancer.
    Bønløkke S; Steiniche T; Sorensen BS; Nyvang GB; Lindegaard JC; Blaakær J; Bertelsen J; Fuglsang K; Strube ML; Lenz S; Stougaard M
    Mol Oncol; 2024 May; 18(5):1231-1244. PubMed ID: 37853962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions.
    Ye J; Zheng L; He Y; Qi X
    MedComm (2020); 2023 Oct; 4(5):e368. PubMed ID: 37719443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic Review.
    Chen X; Zhang P; Chen S; Zhu H; Wang K; Ye L; Wang J; Yu J; Mei S; Wang Z; Cheng X
    Front Oncol; 2020; 10():1733. PubMed ID: 33117670
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of human papillomavirus integration with better patient outcomes in oropharyngeal squamous cell carcinoma.
    Pinatti LM; Sinha HN; Brummel CV; Goudsmit CM; Geddes TJ; Wilson GD; Akervall JA; Brenner CJ; Walline HM; Carey TE
    Head Neck; 2021 Feb; 43(2):544-557. PubMed ID: 33073473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of Human Papillomavirus Type 16 Genetic and Epigenetic Profiles in Cervical Cancer Patients Is Indicative of Poor Disease Prognosis: A Cohort Analysis.
    Dutta S; Singh RK; Mandal RK; Roychoudhury S; Basu P; Panda CK
    Int J Gynecol Cancer; 2016 May; 26(4):750-7. PubMed ID: 27051049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers.
    Szarka K; Veress G; Juhász A; Kónya J; Sápy T; Soós G; Hernádi Z; Gergely L
    Anticancer Res; 2000; 20(3B):2161-7. PubMed ID: 10928171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the HPV integration and its progression to cervical cancer.
    Oyervides-Muñoz MA; Pérez-Maya AA; Rodríguez-Gutiérrez HF; Gómez-Macias GS; Fajardo-Ramírez OR; Treviño V; Barrera-Saldaña HA; Garza-Rodríguez ML
    Infect Genet Evol; 2018 Jul; 61():134-144. PubMed ID: 29518579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Presence of Human Papillomavirus DNA Integration is Associated with Poor Clinical Results in Patients with Third-Stage Cervical Cancer.
    Kiseleva VI; Mkrtchyan LS; Ivanov SA; Lyubina LV; Bezyaeva GP; Panarina LV; Krikunova LI; Zamulaeva IA
    Bull Exp Biol Med; 2019 Nov; 168(1):87-91. PubMed ID: 31768781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology.
    Liu Y; Lu Z; Xu R; Ke Y
    Oncotarget; 2016 Feb; 7(5):5852-64. PubMed ID: 26735580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
    Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
    J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.